Document is current

Any future updates will be listed below

Metformin, Sulfonylureas, DPP-4 Inhibitors and Cardiovascular Outcomes in Type 2 DM

Crossref DOI link: https://doi.org/10.1007/978-3-031-13177-6_32

Published Online: 2023-06-02

Published Print: 2023

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark